on 24 Aug 2021
Last Applicant/ Owned by
Regeringsgatan 111
Stockholm
SE
11139
Serial Number
88576540 filed on 13th Aug 2019
Registration Number
6458608 registered on 24th Aug 2021
Correspondent Address
Donna J. Bunton
Filing Basis
1. intent to use
Disclaimer
NO DATA
Pharmaceutical preparations for use in urology, nephrology, gastroenterology, oncology and immunology and for the treatment of diabetes, infectious diseases, inflammation and metabolic diseases, all for therapeutic use; pharmaceutical preparations for the treatment of kidney stones; pharmaceutical products for the treatment and prevention of kidney diseases in patients with hyperoxaluria Retail sRead More
Pharmaceutical preparations for use in urology, nephrology, gastroenterology, oncology and immunology and for the treatment of diabetes, infectious diseases, inflammation and metabolic diseases, all for therapeutic use; pharmaceutical preparations for the treatment of kidney stones; pharmaceutical products for the treatment and prevention of kidney diseases in patients with hyperoxaluria
Retail store services featuring goods in the fields of pharmaceuticals, medical preparations, vaccines, natural remedies, diagnostics and medical devices; goods import-export agencies; sales promotion for others in the fields of pharmaceuticals, medical preparations, vaccines, natural remedies, diagnostics and medical devices
Scientific and technological services, namely, research and design in the fields of pharmaceutics, tissue engineering and regenerative medicine; analysis of industrial fluids and scientific research services; medical, biological, chemical and scientific research; industrial research in the fields of pharmaceutics, tissue engineering and regenerative medicine; pharmaceutical research and development; research and development of new products in the nature of new medicines and medical preparations; medical and chemical laboratories; clinical testing, namely, conducting clinical trials for others in the fields of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of new products in the nature of probes, reagents and bioassays for industrial and scientific purposes; advisory, consultancy and information services relating to the provision of the aforesaid mentioned services, namely, advisory and consultancy services relating to medical, biological, chemical and scientific research, industrial research in the fields of pharmaceutics, tissue engineering and regenerative medicine, pharmaceutical research and development and conducting clinical trials and providing information in the fields of medical research, biological research, chemical research, scientific research and industrial research in the fields of pharmaceutics, tissue engineering and regenerative medicine
No 88576540
No Service Mark
No DJB/2739-180
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 24th Aug 2021 | REGISTERED-PRINCIPAL REGISTER |
| 08th Jun 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 08th Jun 2021 | PUBLISHED FOR OPPOSITION |
| 19th May 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 03rd May 2021 | ELECTRONIC RECORD REVIEW COMPLETE |
| 30th Apr 2021 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 29th Apr 2021 | EXAMINER'S AMENDMENT ENTERED |
| 29th Apr 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 29th Apr 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 29th Apr 2021 | EXAMINERS AMENDMENT E-MAILED |
